Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Concern and continuity in the care of cancer patients and their carers: development of the intervention
ISRCTN ISRCTN43339432
ClinicalTrials.gov identifier
Public title Concern and continuity in the care of cancer patients and their carers: development of the intervention
Scientific title
Acronym N/A
Serial number at source SDO/13/2001 (e)
Study hypothesis That the development and testing of a complex intervention will lead to improved continuity of care in cancer for patients and those close to them by the delivery of the planned intervention.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Continuity of care in cancer
Participants - inclusion criteria 1. Aged over 18 years
2. Able to give informed consent
3. Patients diagnosed with breast, lung or colorectal cancer, or their nominated relative or friend
Participants - exclusion criteria 1. Unable to give informed consent
2. Aged under 18 years
Anticipated start date 01/04/2006
Anticipated end date 30/09/2007
Status of trial Completed
Patient information material
Target number of participants 80 patients with up to two nominated relatives or friends
Interventions A feasibility (phase II) randomised trial in which we are developing and testing a new intervention - this will be a form of care record for teams in which aspects of continuity of care for each patient will be assessed.
ECAP - engagement and continuity action plan: a continuity of care risk assessment completed by secondary care workers at multi-disciplinary meeting.
Primary outcome measure(s) 1. Acceptability
2. Practicality and feasibility of ECAP
3. Improved patient experience of engagement with care
Secondary outcome measure(s) 1. Economic benefits
2. Patient and nominated friend/family member well being
Sources of funding NHS Service and Delivery Organisation (UK) [ref: SDO/13/2001 (e)]
Trial website
Publications 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/19107130
Contact name Prof  Michael  King
  Address Dept Mental Health Sciences
Royal Free and University College Medical School
Rowland Hill Street
  City/town London
  Zip/Postcode NW3 2PF
  Country United Kingdom
  Tel +44 (0)20 7794 0500
  Fax +44 (0)20 7830 2808
  Email m.king@medsch.ucl.ac.uk
Sponsor University College London (UK)
  Address Gower Street
  City/town London
  Zip/Postcode WC1E 6BT
  Country United Kingdom
  Tel +44 (0)20 7679 2000
  Email vicky.latter@royalfree.nhs.uk
Date applied 13/09/2005
Last edited 10/08/2009
Date ISRCTN assigned 17/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central